会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 2-(substituted pyrrolidinylthio)carbapenem derivatives
    • 2-(取代的吡咯烷硫基)碳青霉烯衍生物
    • US5374720A
    • 1994-12-20
    • US780142
    • 1991-10-21
    • Susumu NakagawaNorikazu OhtakeFumio NakanoKoji YamadaRyosuke UshijimaSatoshi MuraseHiroshi Fukatsu
    • Susumu NakagawaNorikazu OhtakeFumio NakanoKoji YamadaRyosuke UshijimaSatoshi MuraseHiroshi Fukatsu
    • C07D477/20C07D487/04A61K31/40
    • C07D477/20
    • A compound of the formula: ##STR1## wherein R is a hydrogen atom or a methyl group, R.sup.1 is a hydrogen atom or a negative charge, each of R.sup.2 and R.sup.3 which may be the same or different, is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a formimidoyl group, an acetoimidoyl group, --COOR.sup.4, --CON(R.sup.5)R.sup.6, --N(R.sup.5)R.sup.6, --CH.sub.2 COOR.sup.4, --CH.sub.2 N(R.sup.5)R.sup.6 or --CH.sub.2 CON(R.sup.5)R.sup.6 (wherein R.sup.4 is a hydrogen atom or a lower alkyl group, each of R.sup.5 and R.sup.6 which may be the same or different, is a hydrogen atom or a lower alkyl group, or R.sup.5 and R.sup.6 form together with the adjacent nitrogen atom a heterocyclic group selected from the group consisting of an aziridinyl group, an azetidinyl group, a pyrrolidinyl group and a piperidyl group), A is .dbd.NR.sup.7, .dbd.N.sup.+ (R.sup.7)R.sup.8, wherein each of R.sup.7 and R.sup.8 which may be the same or different, is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a formimidoyl group, an acetoimidoyl group, --COOR.sup.4, --CON(R.sup.5)R.sup.6, --N(R.sup.5)R.sup.6, --CH.sub.2 COOR.sup.4, --CH.sub.2 N(R.sup.5)R.sup.6 or --CH.sub.2 CON(R.sup.5)R.sup.6 (wherein R.sup.4, R.sup.5 and R.sup.6 are as defined above), p is an integer of from 0 to 3, and q is an integer of from 1 to 3; or a pharmaceutically acceptable salt or ester thereof.
    • 下式的化合物:其中R是氢原子或甲基,R 1是氢原子或负电荷,R 2和R 3可以相同或不同,为氢原子 ,低级烷基,羟基低级烷基,亚氨基,亚氨酰基,-COOR4,-CON(R5)R6,-N(R5)R6,-CH2COOR4,-CH2N(R5)R6或-CH2CON( R5)R6(其中R4是氢原子或低级烷基,R5和R6各自可以相同或不同,是氢原子或低级烷基,或R5和R6与相邻的氮原子一起形成) 选自氮丙啶基,氮杂环丁烷基,吡咯烷基和哌啶基的杂环基),A为= NR 7 = N +(R 7)R 8,其中R 7和R 8可以相同或不同, 不同的是氢原子,低级烷基,羟基低级烷基,亚氨基,亚氨代乙酰基,-COOR4,-CON(R5)R6,-N(R5)R6,-CH2COOR4,-CH2N(R5 )R6或-CH2CON(R5)R6(其中 在R4中,R5和R6如上所定义),p是0-3的整数,q是1至3的整数; 或其药学上可接受的盐或酯。
    • 4. 发明授权
    • Aminoalkylpyrrolidinylthiocarbapenem derivatives
    • 氨基烷基吡咯烷基硫代碳青霉烯衍生物
    • US5550121A
    • 1996-08-27
    • US312619
    • 1994-09-27
    • Susumu NakagawaShinji KatoSatoshi MuraseOsamu OkamotoRyuji MitomoKatsumi YamamotoKoji YamadaHiroshi Fukatsu
    • Susumu NakagawaShinji KatoSatoshi MuraseOsamu OkamotoRyuji MitomoKatsumi YamamotoKoji YamadaHiroshi Fukatsu
    • C07D207/12C07D477/20C07D487/04A61K31/40
    • C07D477/20C07D207/12
    • A compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or a methyl group, R.sup.2 is a hydrogen atom or a negative charge, R.sup.3 is a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkoxy group, a lower alkanoyloxy group, an amino group, an N-lower alkylamino group, an N,N-di-lower alkylamino group, a lower alkanoylamino group, an aroylamino group, a (lower alkylsulfonyl)amino group, a sulfamoylamino group, a cyano group, a nitro group, a group of --COOR.sup.4 (wherein R.sup.4 is a hydrogen atom or a lower alkyl group) or a group of --CON(R.sup.5)R.sup.6 (wherein each of R.sup.5 and R.sup.6 which may be the same or different, is a hydrogen atom or a lower alkyl group, or R.sup.5 and R.sup.6 form together with the adjacent nitrogen atom a heterocyclic group selected from the group consisting of an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidyl group, a piperazinyl group, a 4-lower alkyl piperazinyl group and a morpholino group), A is a linear or branched lower alkylene group, X is a group of --N(R.sup.7)R.sup.8 (wherein each of R.sup.7 and R.sup.8 which may be the same or different, is a hydrogen atom or a lower alkyl group) or a group of --N.sup.+ (R.sup.9)(R.sup.10)R.sup.11 (wherein each of R.sup.9, R.sup.10 and R.sup.11 which may be the same or different, is a lower alkyl group), provided that when A is a linear lower alkylene group, R.sup.3 is other than a hydrogen atom; or a pharmaceutically acceptable salt or ester thereof.
    • 下式的化合物:其中R1是氢原子或甲基,R2是氢原子或负电荷,R3是氢原子,卤素原子,羟基,低级烷氧基 低级烷酰氧基,氨基,N-低级烷基氨基,N,N-二低级烷基氨基,低级烷酰基氨基,芳酰氨基,(低级烷基磺酰基)氨基,氨磺酰氨基, 氰基,硝基,-COOR 4(其中R 4是氢原子或低级烷基)或-CON(R 5)R 6(其中R 5和R 6可以相同或不同)的基团 是氢原子或低级烷基,或者R 5和R 6与相邻的氮原子一起形成选自氮丙啶基,氮杂环丁烷基,吡咯烷基,哌啶基,哌嗪基的杂环基 ,4-低级烷基哌嗪基和吗啉代基),A为直链或支链低级亚烷基,X为杂环 -N(R 7)R 8(其中可以相同或不同的R7和R8各自为氢原子或低级烷基)或-N +(R 9)(R 10)R 11(其中每个 R 9,R 10和R 11可以相同或不同,为低级烷基),条件是当A为直链低级亚烷基时,R 3不是氢原子; 或其药学上可接受的盐或酯。
    • 6. 发明授权
    • Carbapenem derivatives
    • 卡巴培南衍生物
    • US5707987A
    • 1998-01-13
    • US696910
    • 1996-08-23
    • Susumu NakagawaHiroshi FukatsuRyosuke Ushijima
    • Susumu NakagawaHiroshi FukatsuRyosuke Ushijima
    • A61K31/407A61K31/695A61P31/04C07D477/20C07D519/06C07F7/10A61K31/40C07D487/04
    • C07D477/20
    • A compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or a lower alkyl group, R.sup.2 is a hydrogen atom or a negative charge, R.sup.3 is a hydrogen atom or a lower alkyl group, Ar is a phenyl group, a naphthyl group or a group of: ##STR2## (wherein each of A.sub.4 and A.sub.5 is a single bond, --NHSO.sub.2 -- or the like, and Het is a pyrrolinyl group, a 1,4-diazabicyclo�2.2.2!octanyl group or the like which may be substituted with a hydroxyl group, a carbamoyl lower alkyl group or the like) which may be substituted with a lower alkyl group, a lower alkylsulfamoyl group or the like which may be substituted with a hydroxyl group, a di-lower alkylsulfonyl group or the like; a hydroxyl group; a di-lower alkylsulfamoyl group or the like, each of A.sub.1, A.sub.2 and A.sub.3 is a single bond or a lower alkylene group which may be substituted with a lower alkyl group, a lower alkylsulfamoyl group or the like which may be substituted with a hydroxyl group, a di-lower alkylsulfamoyl group or the like; a pyridyl group or a pyridino group; and W is a sulfur atom, a single bond; or a pharmaceutically acceptable salt or ester; a process for its production and an antibacterial agent containing it as an active ingredient.
    • PCT No.PCT / JP95 / 00280 Sec。 371日期:1996年8月23日 102(e)日期1996年8月23日PCT提交1995年2月24日PCT公布。 公开号WO95 / 23150 PCT 日期:1995年8月31日具有下式的化合物:其中R 1为氢原子或低级烷基,R 2为氢原子或负电荷,R 3为氢原子或低级烷基, Ar是苯基,萘基或基团,-NHSO 2 - 等,Het是可被取代的吡咯啉基,1,4-二氮杂双环[2.2.2]辛烷基等 可以被可被羟基,二低级烷基磺酰基等取代的低级烷基,低级烷基氨磺酰基等取代的羟基,氨基甲酰基低级烷基等)。 羟基; 二低级烷基氨磺酰基等,A1,A2和A3各自为可以被羟基取代的低级烷基,低级烷基氨磺酰基等取代的单键或低级亚烷基 基,二低级烷基氨磺酰基等; 吡啶基或吡啶基; W是硫原子,单键; 或药学上可接受的盐或酯; 其生产方法和含有它作为活性成分的抗菌剂。